Area of research
Molecular Biology · Genetics
Research interest
Research interests include Hedgehog Signaling Pathway Studies, Glioma Diagnosis and Treatment, Epigenetics and DNA Methylation, and Acute Myeloid Leukemia Research.
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip
Failure of human rhombic lip differentiation underlies medulloblastoma formation
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation
The transcriptional landscape of Shh medulloblastoma
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation Is Safe, Effective, and Leads to MRD-Negative Complete Remissions
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Ivosidenib or Enasidenib Combined with Standard Induction Chemotherapy Is Well Tolerated and Active in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation: Initial Results from a Phase 1 Trial
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
EAG2 potassium channel with evolutionarily conserved function as a brain tumor target
Cytogenetic Prognostication Within Medulloblastoma Subgroups
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Subgroup-specific structural variation across 1,000 medulloblastoma genomes